| Emad N Ghobrial, RPH | |
|
409 Pepper Dr Apt F, Hanford, CA 93230-7064 | |
| (559) 415-9818 | |
| Not Available |
| Full Name | Emad N Ghobrial |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 409 Pepper Dr Apt F, Hanford, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023307618 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 60780 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emad N Ghobrial, RPH 409 Pepper Dr Apt F, Hanford, CA 93230-7064 Ph: (559) 415-9818 | Emad N Ghobrial, RPH 409 Pepper Dr Apt F, Hanford, CA 93230-7064 Ph: (559) 415-9818 |
News Archive
Introducing competing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade, according to new analysis from the RAND Corporation.
A novel family of experimental agents that blocks a molecule from shuttling proteins out of the cell nucleus might offer a new treatment for people with acute leukemia, according to a study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Massachusetts General Hospital (MGH) researchers and their colleagues have used digital versions of a standard molecular biology tool to detect a common tumor-associated mutation in the cerebrospinal fluid (CSF) of patients with brain tumors. In their report being published in the open-access journal Molecular Therapy - Nucleic Acids, the investigators describe using advanced forms of the gene-amplification technology polymerase chain reaction (PCR) to analyze bits of RNA carried in membrane-covered sacs called extracellular vesicles for the presence of a tumor-associated mutation in a gene called IDH1.
Retractable Technologies, Inc., a leading maker of safety needle devices, announced that a final judgment and permanent injunction were entered March 4, 2010 in the litigation of Retractable Technologies, Inc. v. OMI (Occupational & Medical Innovations Limited, an Australian company).
The label used to identify a disease - whether it is common language or medical terminology - can influence how serious people think the condition is, according to new research from McMaster University, the second part of a larger study on how people understand and interpret disease.
› Verified 6 days ago
Julius Ombogo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 N 10th Ave, Hanford, CA 93230 Phone: 559-587-9626 Fax: 559-587-9537 | |
Dr. Ronald Anthony Barba, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 N 10th Ave, Hanford, CA 93230 Phone: 559-587-9626 Fax: 559-587-9537 | |
Jerry Isenber, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 710 W Grangeville Blvd, Hanford, CA 93230 Phone: 559-582-9438 | |
Katherine Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 710 W Grangeville Blvd, Hanford, CA 93230 Phone: 559-582-9438 | |
Hamdi Saramah, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 N Douty St, Hanford, CA 93230 Phone: 559-796-0101 Fax: 559-796-0102 | |
Mr. Frank Ralph Quatraro, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 715 W Grangeville Blvd, Hanford, CA 93230 Phone: 559-582-1697 Fax: 559-582-8396 |